Name: | Description: | Size: | Format: | |
---|---|---|---|---|
527.47 KB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
Abstract
End stage renal disease diabetic patients suffer from worse clinical outcomes under dialysis-independently of modality. Peritoneal dialysis offers them the advantages of home therapy while sparing their frail vascular capital and preserving residual renal function. Other benefits and potential risks deserve discussion. Predialysis intervention with early nephrology referral, patient education, and multidisciplinary support are recommended. Skilled and updated peritoneal dialysis protocols must be prescribed to assure better survival. Optimized volume control, glucose-sparing peritoneal dialysis regimens, and elective use of icodextrin are key therapy strategies. Nutritional evaluation and support, preferential use of low-glucose degradation products solutions, and prescription of renin-angiotensin-aldosterone system acting drugs should also be part of the panel to improve diabetic care under peritoneal dialysis
Description
Keywords
Citation
Int J Nephrol. 2011;2011:914849. Epub 2011 Oct 16.
Publisher
SAGE-Hindawi Access to Research